The Institute of Medicine of the National Academies has selected IUPUI’s Jake Chen, Ph.D., to serve on its committee tasked by the U.S. Food and Drug Administration with strengthening regulatory systems in developing countries as they relate to global health and the life sciences.
The 12-member, nationwide committee was chosen from more than 100 qualified experts in the areas of food and drug regulations, supply chain management, pharmaceuticals, disease control and more. Chen serves as the committee’s information technology expert. Chen is an associate professor at the IU School of Informatics and Computing at IUPUI and director of the Indiana Center for Systems Biology and Personalized Medicine, a research Signature Center of IUPUI.
Chen and fellow committee members will convene a consensus study to assist the FDA in identifying the core elements, priorities and strategic approaches necessary to building sustainable regulatory systems in the approximately 150 low- and middle-income countries categorized as “developing.” The study will limit its focus to only those nations that currently are or are expected to soon become major pharmaceutical and agricultural trading partners with the U.S.A. (e.g., Mexico, Brazil, South Africa, India, Thailand and China).
The committee is headed by Dr. Jim Riviere, an elected member of the IOM and a Burroughs Wellcome Fund Distinguished Professor of Pharmacology at North Carolina State University. Also serving are former FDA Commissioner Dr. Jane Henney, former Pfizer Senior Vice President Dr. Martha Brumfield, and Dr. Prashant Yadav, professor of life science supply chain at Massachusetts Institute of Technology.
About the Indiana Center for Systems Biology and Personalized Medicine
The Indiana Center for Systems Biology and Personalized Medicine is a research Signature Center of IUPUI. It brings new discoveries in biology to clinical applications. As scientists collaborate to enhance research in the genetic and cellular function of biological systems, the center connects these researchers with clinicians and surgeons treating diseases such as cancer. These collaborations speed the translation of the latest advances in understanding disease biology into cost-effective, personalized diagnoses and treatment of patients.
Media Contact
Joanne Lovrinic
jebehele@iu.edu
317-278-9208